Mainz, Germany

Thomas Woelfel


Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2004-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Thomas Woelfel

Introduction: Thomas Woelfel, an accomplished inventor based in Mainz, Germany, holds three patents in the field of immunology and cancer treatment. His groundbreaking work focuses on novel tumor-associated antigens that elicit immune responses independently of Major Histocompatibility Complex (MHC) presentation, paving the way for advancements in cancer therapies.

Latest Patents: Woelfel's latest patents include innovative findings on MHC-independent tumor-associated antigens that trigger CD8-positive T-cell responses. His work on the GM-CSF-Receptor alpha chain (CSF2RA) and Tyrosinase-related protein 2 (TRP-2) outlines the identification of these antigens as targets for CD8-positive T-cell clones. The patents detail the development of proteins, protein fragments, and polypeptides derived from these novel antigens, which are intended for use in medical treatments for tumor diseases. Additionally, his inventions describe nucleic acids that express these antigens, binding agents such as T-cell receptor chains, and isolated T cells which are reactive to these antigens. Furthermore, he explores pharmaceutical compositions, particularly vaccine formulations, and methods for generating T cells that are MHC-independently reactive.

Career Highlights: Throughout his career, Thomas Woelfel has made significant contributions within reputable organizations. He has worked at Boehringer Ingelheim International GmbH and BioNTech RNA Pharmaceuticals GmbH, where he honed his expertise in immunology and cancer research.

Collaborations: During his professional journey, Woelfel has collaborated with notable colleagues, including Dirk Schadendorf and Annette Paschen. This collaboration has further enhanced the research quality and impact of his inventions.

Conclusion: Thomas Woelfel is a distinguished inventor whose innovative work in the field of immunology has the potential to transform cancer treatment. His patents reflect a commitment to developing new therapeutic strategies that could significantly improve patient outcomes through cutting-edge technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…